Information Journal Paper
APA:
Copy. (2020). Risks of ACE inhibitor and ARB usage in COVID-19: Evaluating the evidence. Clinical Pharmacology and Therapeutics, 108(2), 0-0. SID. https://sid.ir/paper/989527/en
Vancouver:
Copy. Risks of ACE inhibitor and ARB usage in COVID-19: Evaluating the evidence. Clinical Pharmacology and Therapeutics[Internet]. 2020;108(2):0-0. Available from: https://sid.ir/paper/989527/en
IEEE:
Copy, “Risks of ACE inhibitor and ARB usage in COVID-19: Evaluating the evidence,” Clinical Pharmacology and Therapeutics, vol. 108, no. 2, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/989527/en